Myoclonus in adult Huntington's disease.
نویسندگان
چکیده
Two brothers with clinically definite adult Huntington's disease developed disabling myoclonus years after the first signs of the disease. Their electroencephalograms were consistent with a primary generalized epilepsy, although neither man had seizures. The myoclonus was controlled with valproic acid therapy.
منابع مشابه
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series
BACKGROUND Chorea in Huntington's Disease (HD) is usually treated with antidopaminergic neuroleptics like haloperidol, olanzapine and tiaprid or dopamine depleting drugs like tetrabenazine. Some patients with hyperkinesia, however, react to treatment with antidopaminergic drugs by developing extrapyramidal side effects. In earlier studies valproic acid showed no beneficial effect on involuntary...
متن کاملBehavioral study of effects of mesenchymal stem cells transplant on motor deficits improvement in animal model of Huntington\'s disease
Introduction: As an inherited neurodegenerative disease, Huntington's disease is accompanied with wide neuronal degeneration in neostriatum and neocortex. Progress of the disease causes disabling clinical effects on movements, recognition and physiology of the body, and finally results in death. At this stage of knowledge we are, there is no effective therapeutic strategy for diminishing the mo...
متن کاملTetrabenazine in the treatment of Huntington’s disease
Tetrabenazine (TBZ), a catecholamine-depleting agent initially developed for the treatment of schizophrenia, when tested for other indications, has proven to be more useful for the treatment of a variety of hyperkinetic movement disorders. These disorders include neurological diseases characterized by abnormal involuntary movements such as chorea associated with Huntington's disease, tics in To...
متن کاملSpeech–Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function
BACKGROUND Hyperkinetic dysarthria is characterized by abnormal involuntary movements affecting respiratory, phonatory, and articulatory structures impacting speech and deglutition. Speech-language pathologists (SLPs) play an important role in the evaluation and management of dysarthria and dysphagia. This review describes the standard clinical evaluation and treatment approaches by SLPs for ad...
متن کاملA new approach: Valproic acid in Huntington’s Disease. Dose dependent improvement of myoclonic hyperkinesia: an Open-Label, Observational Study in a subgroup
Background: Huntington’s Disease (HD) is characterized by choreatic movements. Chorea is treated with antidopaminergic neuroleptics like tiaprid and tetrabenazine. Especially in patients with signs of parkinsonism antidopaminergic medication often leads to a worsening of symptoms. In earlier studies valproic acid showed no beneficial effect on involuntary movements. Myoclonus is rare in HD and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of neurology
دوره 29 2 شماره
صفحات -
تاریخ انتشار 1991